Page 226 - HIVMED_v21_i1.indb

Page 8 of 9 Original Research

6. Moosa MR, Meyers AM, Gottlich E, Naicker S. An effective approach to chronic 18. Glencross D, Scott LE, Jani IV, Barnett D, Janossy G. CD45-assisted PanLeucogating
kidney disease in South Africa. S Afr Med J. 2016;106(2):156–159. https://doi. for accurate, cost-effective dual-platform CD4+ T-cell enumeration. Cytometry.
org/10.7196/SAMJ.2016.v106i2.9928 2002;50(2):69–77. https://doi.org/10.1002/cyto.10068
7. Davids MR, Marais N, Jacobs JC. South African renal registry annual report 2015. 19. Griveas I, Visvardis G, Fleva A, et al. Comparative analysis of immunophenotypic
Afr J Nephrol. 2017;20(1):13. https://doi.org/10.21804/20-1-2583 abnormalities in cellular immunity of uremic patients undergoing either
8. Kilonzo KG, Jones ESW, Okpechi IG, et al. Disparities in dialysis allocation: An hemodialysis or continuous ambulatory peritoneal dialysis. Renal Failure.
audit from the new South Africa. PLoS One. 2017;12(4):e0176041. https://doi. 2005;27(3):279–282. https://doi.org/10.1081/JDI-56620
org/10.1371/journal.pone.0176041 20. Vacher-Coponat H, Brunet C, Lyonnet L, et al. Natural killer cell alterations
9. Jensen CE, Sorensen P, Petersen KD. In Denmark kidney transplantation is more correlate with loss of renal function and dialysis duration in uraemic patients.
cost-effective than dialysis. Dan Med J. 2014;61(3):A4796. Nephrol Dial Transplant. 2008;23(4):1406–1414. https://doi.org/10.1093/ndt/
gfm596
10. Abecassis M, Bartlett ST, Collins AJ, et al. Kidney transplantation as primary
therapy for end-stage renal disease: A National Kidney Foundation/Kidney 21. Deenitchina SS, Ando T, Okuda S, et al. Cellular immunity in hemodialysis patients:
Disease Outcomes Quality Initiative (NKF/KDOQITM) conference. CJASN. A quantitative analysis of immune cell subsets by flow cytometry. Am J Nephrol.
2008;3(2):471–480. https://doi.org/10.2215/CJN.05021107 1995;15(1):57–65. https://doi.org/10.1159/000168802
11. Swinnen LJ. Outcomes of kidney transplantation in HIV-infected recipients. New 22. Rabb H, Agosti SJ, Pollard S, Bittle PA, Ramirez G. Activated and regulatory
Eng J Med. 2011;364(7):683. https://doi.org/10.1056/NEJMc1014114 T lymphocyte populations in chronic hemodialysis patients. Am J Kidney Dis.
12. Lucas GM, Ross MJ, Stock PG, et al. Clinical practice guideline for the management 1994;24(3):443–452. https://doi.org/10.1016/S0272-6386(12)80901-2
of chronic kidney disease in patients infected with HIV: 2014 update by the HIV 23. Fabian J, Maher HA, Clark C, Naicker S, Becker P, Venter WD. Morbidity and
Medicine Association of the Infectious Diseases Society of America. Clin Infect Dis. mortality of black HIV-positive patients with end-stage kidney disease receiving
2014;59(9):e96–e138. https://doi.org/10.1093/cid/ciu617 chronic haemodialysis in South Africa. S Afr Med J. 2015;105(2):110–114. https://
13. Muller E, Barday Z, Mendelson M, Kahn D. HIV-positive-to-HIV-positive kidney doi.org/10.7196/SAMJ.8369
transplantation – Results at 3 to 5 years. New Eng J Med. 2015;372(7):613–620. 24. Meintjes G, Moorhouse MA, Carmona S, et al. Adult antiretroviral therapy
https://doi.org/10.1056/NEJMoa1408896 guidelines 2017. S Afr J HIV Med. 2017;18(1):776. https://doi.org/10.4102/
14. Muller E, Barday Z, Mendelson M, Kahn D. Renal transplantation between HIV- sajhivmed.v18i1.776
positive donors and recipients justified. S Afr Med J. 2012;102(6):497–498. 25. Trullas JC, Barril G, Cofan F, et al. Prevalence and clinical characteristics of HIV type
https://doi.org/10.7196/SAMJ.5754 1-infected patients receiving dialysis in Spain: Results of a Hum Retroviruses
15. Arnold E. The HIV organ policy equity act: Offering hope to individuals with end Spanish survey in 2006: GESIDA 48/05 study. AIDS Res. 2008;24(10):1229–1235.
stage renal disease and HIV. Nephrol Nursing J. 2017;44(3):230–249. https://doi.org/10.1089/aid.2008.0158
16. Office E. Guidelines for renal replacement therapy in HIV-infected individuals in 26. Kedzierska K, Crowe SM. Cytokines and HIV-1: Interactions and clinical implications.
South Africa. 2008;9(2), a655. https://doi.org/10.4102/sajhivmed.v9i2.655 Antivir Chem Chemother. 2001;12(3):133–150. https://doi.org/10.1177/ 0956
17. Suarez JF, Rosa R, Lorio MA, et al. Pretransplant CD4 count influences immune 32020101200301
reconstitution and risk of infectious complications in human immunodeficiency 27. Fontana D, Schut R, Rabb H. Can choice of dialyser membrane have a beneficial
virus-infected kidney allograft recipients. Am J Transplant. 2016;16(8):2463–2472. effect on HIV load in the HIV-infected dialysis patient? Nephrol Dial Transplant.
https://doi.org/10.1111/ajt.13782 2002;17(3):529–530. https://doi.org/10.1093/ndt/17.3.529

http://www.sajhivmed.org.za 218 Open Access